Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. [electronic resource]
Producer: 20051011Description: 646-56 p. digitalISSN:- 0149-2918
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- economics
- Antirheumatic Agents -- economics
- Arthritis, Rheumatoid -- drug therapy
- Cohort Studies
- Drug Therapy, Combination
- Etanercept
- Female
- Health Care Costs
- Humans
- Immunoglobulin G -- economics
- Infliximab
- Insurance Coverage
- Insurance, Health
- Male
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.